L. Prats

Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data

C. Gerloff, D. Blacker, C. Anderson, 2020, The Lancet.

Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial.

S. M. Park, M. N. Duy, Le Tuan Linh, 2019, Lancet.

Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trial

C. Gerloff, T. Neumann-Haefelin, M. Endres, 2020, Neurological Research and Practice.

Workflow Times and Outcomes in Patients Triaged for a Suspected Severe Stroke

Juan B. Gómez, J. C. Molina, Jose Carlos Molina, 2022, Annals of neurology.

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.

D. Tanné, D. Blacker, S. Connolly, 2018, The Lancet. Neurology.

Impact of a comprehensive stroke centre on the care of patients with acute ischaemic stroke due to cervical artery dissection.

E. López‐Cancio, M. Millán, M. Hernández-Pérez, 2015 .

Impact of a comprehensive stroke centre on the care of patients with acute ischaemic stroke due to cervical artery dissection.

M. Millán, M. Hernández-Pérez, M. Gomis, 2015, Neurologia.